VC

Vikas Chandra Verma

Active Director Managing Director DIN 02143867
DIN 02143867 First appointment Jan 2007 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Vikas Chandra Verma

Data last updated:

Vikas Chandra Verma is a Managing Director at Parv Pharmaceuticals Private Limited (since 2007). The company operates in Trading.

DIN 02143867
Primary Designation Managing Director
Industry Trading
First Appointment 25 Jan 2007
Oldest Company Age 19 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Parv Pharmaceuticals Private Limited U51397BR2007PTC012814
Managing Director25 Jan 20072007Under Process Of Striking Off

Board colleagues of Vikas Chandra Verma

NameDINCompanyDesignation
Meeta Sinha02143838Parv Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Parv Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vikas Chandra Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vikas Chandra Verma

Vikas Chandra Verma currently holds 1 directorship: Parv Pharmaceuticals Private Limited (Managing Director, since 25 Jan 2007).

Vikas Chandra Verma was first appointed on 25 Jan 2007 as Managing Director at Parv Pharmaceuticals Private Limited.

The current boards of Vikas Chandra Verma's companies include Meeta Sinha (Parv Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available